In re Viloxazine

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY Civil Action No. 25-12183 (MEF) (MAH) IN RE VILOXAZINE OPINION The non-Zydus Defendants,1 through Defendants Zenara Pharma Private Limited and Biophore Pharma Inc., seek leave to amend their invalidity contentions and join the Zydus Defendants’ contentions for the method-of-treatment patents. June 10, 2026 Letter from Non- Zydus Defendants, D.E. 111. Plaintiff Supernus Pharmaceuticals, Inc. (“Supernus” or “Plaintiff”) opposes the request on two grounds: (1) the non-Zydus Defendants have not demonstrated good cause or adequate diligence; and…